Toggle menu

New Study: MAPP2 has begun

Posted by | 5 Jul 2018

New Study: MAPP2 has begun

The aim of the study is to establish a biobank of human serum samples from patients with paracetamol overdose to develop and test the performance of our point of care test. To find out more, go to: http://www.emergeresearch.org/trial/mapp2/

ACE SERIES: Nutrition in Survivors of Critical Illness: A Canadian Perspective ACE Series: Towards precision medicine in acute pancreatitis. READ ALL ABOUT IT- EMERGE Summer Newsletter is out

READ ALL ABOUT IT- EMERGE Summer Newsletter is out

19 Jul 2019 |

Find out who has become a professor, which multi-centre study has closed and who has joined the EMERGE team!

Read more